Healthcare -
Biotechnology - NASDAQ - BM
$ 18.54
0.816 %
$ 1.34 B
Market Cap
-154.5
P/E
KNSA - PRE-TAX INCOME
Pre-tax Income KNSA - Kiniksa Pharmaceuticals, Ltd.
-16.7 M
LAST VALUE
67.38%
2 YEAR CAGR
30.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR